- Policy & Regulation
- Regional Views
- Regulatory Trackers
- Pink Sheet Originals
- Featured Topics
Jane Barlow
Advertisement
Latest From Jane Barlow
Commercializing Rare Disease Therapies Is Getting Tougher
Bookmark
-
Analysis
For an industry increasingly dominated by these drugs, commercial programs need to take on the risk once reserved for development.
Paying for Pharmaceutical Value: The Problem of a One-Size-Fits-All Definition
Bookmark
-
Opinion
It is a world, at least the US corner of it, in which any common understanding of drug value is confused by opposing incentives – to opacity and transparency, to looking at benefit broadly or narrowly, long-term or short-term: value, in short, to whom?
Advertisement
Brian Yang
Email Author
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.